Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from β-blockers and prostaglandin analogs.
about
Interventions for improving adherence to ocular hypotensive therapyCombination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focusCorneal epithelial toxicity of antiglaucoma formulations: in vitro study of repeated applicationsSwitching from concomitant therapy to tafluprost/timolol fixed combination.Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma
P2860
Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from β-blockers and prostaglandin analogs.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Ocular hypotensive effect and ...... ers and prostaglandin analogs.
@ast
Ocular hypotensive effect and ...... ers and prostaglandin analogs.
@en
type
label
Ocular hypotensive effect and ...... ers and prostaglandin analogs.
@ast
Ocular hypotensive effect and ...... ers and prostaglandin analogs.
@en
prefLabel
Ocular hypotensive effect and ...... ers and prostaglandin analogs.
@ast
Ocular hypotensive effect and ...... ers and prostaglandin analogs.
@en
P2093
P2860
P356
P1476
Ocular hypotensive effect and ...... ers and prostaglandin analogs.
@en
P2093
Akira Setogawa
Goji Tomita
Kenji Inoue
Masato Wakakura
Risako Higa
Ryo Moriyama
P2860
P304
P356
10.2147/OPTH.S29062
P407
P577
2012-02-10T00:00:00Z